GRAIL has announced that two of its executives will be speaking at the BofA Securities 2020 Health Care Conference. Hans Bishop, Chief Executive Officer; and Joshua Ofman, MD, MSHS, Chief Medical Officer and External Affairs, will provide an overview of the company at the virtual conference,...
Vivante Health, a provider of digital medicine tools for digestive health and disease, has joined the Accolade Partner Ecosystem as part of the company’s Trusted Supplier Program. GIThrive is Vivante’s digital gut health platform. Using proprietary algorithms and data from each user’s symptom and food log,...
In response to the COVID-19 pandemic, the HLTH Matters Blog Series will be interviewing experts from across the health ecosystem to bring timely facts and updates to the HLTH community. A post written by Aetion CEO Carolyn Magill details the role of real-world evidence in...
Electronic health record software provider Epic released data indicating that appointments for cervix, colon, and breast cancer screenings have dropped between 86 percent and 94 percent compared to average volumes in the three years before the confirmation of the first COVID-19 case in the U.S. At...
Aetion has issued a call for the FDA to implement a cloud-based real-world evidence (RWE) platform with robust data governance so that users can do data queries, archiving, access, and aggregation. Such a system, the company says, could help avoid unnecessary data duplication and support...
GRAIL announced that it has completed a $390 million Series D financing round. New investors including Public Sector Pension Investment Board (PSP Investments), Canada Pension Plan Investment Board (CPP Investments), and two undisclosed investors joined existing backers including Illumina in this round of funding. “GRAIL is...
Experts say the U.S. will need about 300,000 human tracers to chart and break ongoing expansion of the coronavirus pandemic, but we currently only have between 8,000 and 14,000. In a recent Rock Health post, the firm recommends combining a surge in human tracers, digital...
Novartis has announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of its Enerzair® Breezehaler® as a maintenance treatment of asthma in adult patients not adequately controlled with currently recommended maintenance...
One benefit of the coronavirus pandemic is the increasing usage of telehealth. The virus has forced an end to many non-urgent medical visits, and doctors are connecting with COVID and non-COVID patients virtually. According to Dr. Roy Schoenberg, CEO of telehealth company Amwell, telehealth has...
The COVID-19 crisis has brought telehealth to the forefront as a way to screen for the disease and to manage care for high-risk patients with chronic illnesses. In fact, among U.S. adults, two-thirds said COVID-19 has made them more willing to try telehealth options. According to...